Official Title

Exploratory Non Comparative Study to Evaluate the Efficacy of Highly Bioavailable Curcumin (Flexofytol) in Patients With Knee Osteoarthritis
  • Phase

    Early Phase 1
  • Study Type

    Interventional
  • Status

    Completed No Results Posted
  • Intervention/Treatment

    curcumin ...
  • Study Participants

    22
The purpose of this study is to evaluate the efficacy of bio-optimized curcumin(Flexofytol) during a 90-days period in knee ostearthritis patients on the serum levels of specific biomarkers of osteoarthritis and on the evaluation of pain.
Study Started
Mar 31
2012
Primary Completion
Dec 31
2012
Study Completion
Dec 31
2012
Last Update
Jun 23
2015
Estimate

Dietary Supplement Flexofytol (bio-optimized curcumin)

2x3 caps/day (before breakfast and in the evening) for 3 months

Flexofytol (bio-optimized curcumin) Experimental

Criteria

Inclusion Criteria:

45 to 80 years of age
Internal femorotibial gonarthrosis responding to the clinical and radiological criteria of ACR
Symptomatic knee for more than 6 months
Mean knee pain on the last 24 hours of at least 40 mm on VAS
Kellgren & Laurence grade II to III
Patients able to avoid NSAIDs and analgesics during the study
Patients having signed informed consent
Patients able to follow the study instructions

Exclusion Criteria:

Related to the osteoarthritis pathology:

Osteoarthritis linked to a metabolic arthropathy
Predominant associated symptomatic femoropatellar osteoarthritis
Chondromatosis or villonodular synovitis of the knee
Recent trauma (< 1 month) of the knee responsible for the pain
Inflammatory flare
Pathology potentially interfering with the evaluation (metabolic inflammatory arthropathy, rheumatoid arthritis, lower limb radiculalgia, arthritis...
Paget disease
Homolateral coxarthrosis
Articular Prosthesis
Knee joint effusion

Related to previous and associated treatments:

Corticosteroids injection in the previous month, whatever the joint concerned,
Hyaluronan injection in the evaluated knee during the previous 6 months,
NSAID or analgesics in the 72 hours prior to inclusion
No modification of Slow-acting drugs for OA and/or dietary supplements taken within less than 6 months prior to the study(ex: chondroitin sulfate, diacerein, soy and avocado unsaponifiables, oxaceprol, granions de cuivre, glucosamine, phytotherapy for OA, homeopathy for OA...),
Anticoagulant (coumarinic) treatment and heparin
General corticotherapy,
Contraindication to paracetamol.

Related to associated pathologies:

Patient suffering from serious associated illness (liver failure, kidney failure, non-controlled cardiovascular diseases...)

Related to patients:

Pregnant or breastfeeding women
Pre-menopausal women with no contraception
Patients unable to write
Patients enrolled in a clinical trial in the previous 3 months
Patients under juristic protection or under guardianship.
No Results Posted